MARY ANN LEEPER, PH.D. - Corporate Board Profile

VERU INC.

Filing Date	Source Excerpt
2006-02-27	Dr. Leeper has served as the President and Chief Operating Officer of the Company since 1996 and will serve in that role until May 1, 2006. Effective May 1, 2006, Dr. Leeper will serve as a strategic adviser to the Company.
2007-02-20	Dr. Leeper has served as Senior Strategic Adviser to the Company since May 2006. Dr. Leeper served as the President and Chief Operating Officer of the Company from 1996 to April 2006. Dr. Leeper served as President and Chief Executive Officer of The Female Health Company Division from May 1994 until January 1996, as Senior Vice President 6 Development of the Company from 1989 until January 1996 and as a Director of the Company since 1987.
2008-02-20	Dr. Leeper has served as Senior Strategic Adviser since May 2006. ... Dr. Leeper is a director of the Company since 1987. ... Mary Ann Leeper receives compensation as our Senior Strategic Adviser pursuant to an employment agreement. ... Director Summary Compensation Table shows total compensation for Mary Ann Leeper as $200,217.
2009-02-24	Dr. Leeper has served as the Company’s Senior Strategic Adviser since May 2006. Dr. Leeper served as the President and Chief Operating Officer of the Company from February 1996 to April 2006, as President and Chief Executive Officer of The Female Health Company Division from May 1994 until January 1996, as Senior Vice President — Development of the Company from 1989 until January 1996 and as a Director of the Company since 1987.
2010-02-26	Dr. Leeper has served as Senior Strategic Adviser since May 2006. ... Dr. Leeper is a shareholder and has served as a Vice President and Director of Phoenix of Illinois since 1987. ... Directors who are executive officers or employees of the Company do not receive compensation for serving as directors. In fiscal 2009, we paid fees to certain of our directors who are not executive officers or employees of the Company for their committee participation. As described below, one of our directors, Mary Ann Leeper, Ph.D., receives compensation as our Senior Strategic Adviser pursuant to an employment agreement, and another director, William R. Gargiulo, Jr. receives consulting fees. They do not receive compensation as directors. ... Director Summary Compensation Table ... Mary Ann Leeper ... Total: $402,949.
2011-02-28	Dr. Leeper has served as Senior Strategic Adviser since May 2006. Dr. Leeper served as the President and Chief Operating Officer of the Company from February 1996 to April 2006, as President and Chief Executive Officer of The Female Health Company Division from May 1994 until January 1996, as Senior Vice President 6 Development of the Company from 1989 until January 1996 and as a Director of the Company since 1987. Dr. Leeper is a shareholder and has served as a Vice President and Director of Phoenix of Illinois since 1987.
2012-02-24	Dr. Leeper has served as Senior Strategic Adviser since May 2006. Dr. Leeper served as the President and Chief Operating Officer of the Company from February 1996 to April 2006, as President and Chief Executive Officer of The Female Health Company Division from May 1994 until January 1996, as Senior Vice President Development of the Company from 1988 until January 1996 and as a Director of the Company since 1987. ... Dr. Leeper's compensation is for the execution of these responsibilities. She does not receive compensation for her role as a director of the Company.
2013-02-25	Dr. Leeper has served as Senior Strategic Adviser since May 2006. Dr. Leeper served as the President and Chief Operating Officer of the Company from February 1996 to April 2006, as President and Chief Executive Officer of The Female Health Company Division from May 1994 until January 1996, as Senior Vice President 6 Development of the Company from 1988 until January 1996 and as a Director of the Company since 1987. Dr. Leeper is a shareholder and has served as a Vice President and Director of Phoenix of Illinois since 1987. From 1981 until 1986, Dr. Leeper served as Vice President 6 Market Development for Searle 2s Pharmaceutical Group and in various Searle research and development management positions. As Vice President 6Market Development, Dr. Leeper was responsible for worldwide licensing and acquisition, marketing and market research. In earlier positions, she was responsible for preparation of new drug applications and was a liaison with the FDA. Dr. Leeper serves on the Board of Neenah Paper, Inc. and is chair of its nominating and governance committee. She also was an adjunct professor at the University of Virginia 2s Darden School of Business from 2001 to 2012. She has received various awards recognizing her commitment and pioneering efforts in the work of women 2s health.